# A Study to Evaluate XTR006 in Chinese Volunteers

> **NCT06151795** · PHASE1 · COMPLETED · sponsor: **Sinotau Pharmaceutical Group** · enrollment: 10 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIAGNOSTIC_TEST:** XTR006

## Key facts

- **NCT ID:** NCT06151795
- **Lead sponsor:** Sinotau Pharmaceutical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-12
- **Primary completion:** 2023-09-27
- **Final completion:** 2024-01-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151795, "A Study to Evaluate XTR006 in Chinese Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06151795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*